Agentic AI is moving biopharma from tools that inform decisions to systems that execute them, reshaping discovery, clinical ...

AI is no longer a future consideration for pharmaceutical supply chain operators, according to Nitin Jayakrishnan, co-founder and CEO of Freehand.

Anthony "TJ" Rizzo, chief commercial officer at Cold Chain Technologies, says the biggest risk his customers face as ...

Associate Editorial Director Chris Cole highlights the top thoughts from you and your pharma industry peers from across Pharmaceutical Commerce during the past 2 weeks while walking his dog, Penny!

Cencora’s Matt Sample and Gregg Gorniak explain why AI should recommend, not decide, and why pharma needs an agent strategy ...

At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how automation cuts human touches, enforces quarantine and ...

In this week's Pharma Pulse, Cencora agrees to acquire American Oncology Network, five major employers back electronic prior ...

FDA finalized guidance setting out how drug sponsors should label, describe and submit content from software used alongside ...

AI is starting to resolve shipment exceptions and flag demand shifts, but early deployments show that connected data and ...

BSI tracked 166 pharmaceutical cargo theft incidents worldwide from 2024 through the first half of 2026. Of those, 78% ...

At LogiPharma USA 2026, BMS’s Kevin Cook explains why CMO partnerships must move beyond transactions toward shared goals and ...

Avantor’s Mary Blenn outlines five considerations for biopharma supply chain localization, from customer demand visibility to ...